Human noroviruses are a major cause of gastroenteritis, yet there are still no vaccines 17 or antivirals available. Nevertheless, a number of vaccine candidates that are currently 18 in clinical trials are composed of norovirus virus-like particles (VLPs). These VLPs 19 are recognized as morphologically and antigenically similar to norovirus virions. An 20 X-ray crystal structure of the prototype (GI.1) VLPs showed that the norovirus capsid 21 has a T=3 icosahedral symmetry and is composed of 180 copies of the major capsid 22 protein (VP1) that folds into three quasi-equivalent subunits (A, B, and C). In this 23 study, we determined the cryo-EM structure of VLPs for two GII.4 noroviruses that 24
IMPORTANCE 36
The discovery that the GII.4 VLPs (identified in 1974 and 2012, termed CHDC-1974 37 and NSW-2012, respectively) have a T=4 symmetry is of major significance, since 38 the NSW-2012 is clinically important and previous structural and biochemical studies 39 assumed noroviruses have a T=3 symmetry and are composed of 180 copies of VP1. 40
More importantly, NSW-2012 norovirus shared 96% amino acid identity with a GII.4 41 vaccine candidate and our data suggests that this vaccine might also have a T=4 42 symmetry. Although it is not clear if the T=4 VLPs were an artifact of the insect cell 43 expression system, the T=4 VLP vaccines might not recognize equivalent epitopes on 44 T=3 virions, which will be important for future neutralization studies. (ORFs), where ORF1 encodes nonstructural proteins and ORF2 and ORF3 encode a 53 major structural protein (termed VP1) and a minor structural protein (termed VP2), 54 respectively. Noroviruses are genetically diverse and based on VP1 sequences there 55 are seven genogroups (GI-GVII), where GI, GII, and GIV cause infections in humans 56
(1, 2). The GI and GII are further subdivided into numerous genotypes, with GII 57 genotype 4 (GII.4) recognized as the most prevalent and clinically important (3, 4). 58
59
Development of an effective norovirus vaccine or antiviral has been hampered by the 60 lack of a suitable cell culture system or small animal model. Moreover, the extensive 61 genetic and antigenic diversity likely hinders vaccine development. Nevertheless, 62 several vaccine candidates have progressed to phase I and II human clinical trials. 63
Most vaccines were composed of norovirus GII.4 or GI.1 virus-like particles (VLPs), 64 which can be produced by expressing VP1 in insect cells. These vaccines were wellCryo-EM data sample preparation and data collection 131 UNSW-2012 and CHDC-1974 VLPs (3 µl) were applied on freshly glow discharged 132
Quantifoil holey carbon support films (R1.2/1.3; Quantifoil) and blotted for 18 133 seconds at 100% humidity at 10°C before been plunged in liquid ethane using an FEI 134
Mark IV Vitrobot (Thermo Fischer Scientific). Vitrified specimens were imaged on a 135
Titan Krios operated at 300 keV. NSW-2012 micrographs were acquired with a K2 136 direct electron detector at 64,000× magnification, corresponding to a pixel size of 137 2.27 Å/px, while CHDC-1974 micrographs were collected using a K3 camera with 138
Latitude S software (Gatan) at 64,000× magnification, corresponding to a pixel size of 139 structures for CHDC-1974 (accession number: EMD-4549) and NSW-2012 (EMD-156 4550) were deposited at EMDB. 157
158
Fitting of the X-ray structures into the density maps 159
Crystal structures of NSW-2012 P domain (PDB ID: 4OOS) and CHDC-1974 P 160 domain (5IYN) were fitted into the respective densities using the "fit in map" 161 command in the UCSF Chimera software (26). Since a high-resolution GII.4 shell 162 domain was unavailable, the GI.1 Norwalk virus S domain was extracted from the X-163 ray crystal structure (1IHM) and fitted into the GII.4 cryo-EM density using UCSF 164
Chimera software. substitutions were located in the P domain. Negative stain EM images revealed that 173 these the VLPs exhibited characteristic norovirus morphology (Fig. 2) . However, the 174 diameter of these VLP images was measured to be ~52 nm, which suggested that the 175 GII.4 VLPs were larger than GII.10 and GI.1 VLPs that had diameters of ~43 nm and 176 38 nm, respectively. 177 178
Cryo-EM structure of GII.4 NSW-2012 VLPs 179
The structure of the NSW-2012 VLPs was determined using cryo-EM. The VLPs 180
were mono-dispersed in vitreous ice and appeared homogenous in size (Fig. 3A) . 181
From the 364 images, 10,548 particles were used for structural reconstruction and 182 refined to 7.3 Å resolution (Fig. 3B) . 183
184
Unexpectedly, NSW-2012 VLPs were discovered to have a T=4 icosahedral 185 symmetry (Fig. 4) . Our data revealed that these VLPs were composed of 240 copies 186 of VP1, rather than the 180 VP1 copies in GI.1 and GII.10 VLPs. The inner diameter 187 of NSW-2012 shell was measured as 32 nm, while the outer capsid diameter was 50 188 nm. Interestingly, this large diameter of the T=4 VLPs corresponded to an inner shellvolume of 17,157 nm 3 , which was ~2.6 times the volume of the GII.10 VLPs that had 190 an inner diameter of 23 nm (13). In order to better comprehend how VP1 assembled into the T=4 VLPs, the X-ray 212 crystal structure of NSW-2012 P domain (4OOS) and GI.1 S domain (1IHM) were 213 fitted into the VLP density map. We found that the NSW-2012 P domain dimer couldbe unambiguously positioned into the VLP structure with cross correlation coefficient 215 of 0.96 (Fig. 7A ). This result indicated that the P domain dimers on the T=4 VLPs had 216 not undergone any major structural modifications. In the case of the S domain, the 217 GI.1 S domain needed to be manually positioned into the density map. The GI.1 S 218 domain fitted well into to A/B dimer and the C subunit, while the D subunit needed to 219 be further repositioned (Fig. 7B ). This additional fitting in the D subunit was 220 necessary in order to occupy the elevated density of the cavity and flap-like regions. 221 222 Unfortunately, it was problematic to fit the hinge region, since the hinge region on the 223 X-ray crystal structure of NSW-2012 P domain was excluded from the expression 224 construct and the hinge region on the GI.1 VLPs was flattened (7, 13). Interestingly, 225
an additional density was also observed between the S domain and the C-terminus of 226 the P domain on the D subunit (Fig. 8 ). This connection appeared to stabilize the bent 227 conformation of the C/D dimer and subsequently the T=4 VLPs. Indeed, the C-228 terminus of VP1 on the GI.1 VLPs and the GII.4 P domain were found to be flexible 229 (7, 28). Interestingly, the C-terminus of VP1 was previously shown to be important 230 for the size and stability of VLPs (29). Therefore, it is possible that GII.4 VP1 231 might be a structural feature of GII noroviruses, since the P domains on the GI.1 240
VLPs were essentially resting on the shell (7). 241 242
Cryo-EM structure of GII.4 CHDC-1974 VLPs 243
Following these results, we proceeded to determine the cryo-EM structure of the 244 CHDC-1974 VLPs. The VLPs were mostly mono-dispersed and homogenous in size 245 (Fig. 9A) . From 591 images, 42,485 particles were used for the structural 246 reconstruction that led to a final resolution of 6.1 Å (Fig. 9B) . Remarkably, the 247 CHDC-1974 VLPs also had a T=4 symmetry (Fig. 10) . In fact, the CHDC-1974 VLP 248 structure closely resembled the structural features of NSW-2012 VLPs. 249
250
We found that CHDC-1974 VLPs were composed of 240 copies of VP1 that formed 251 the equivalent subunits (A, B, C, and D) and A/B and C/D dimers. The inner diameter 252 of the shell was 32 nm, whereas the outer diameter of the capsid was 50 nm. The 253 comparable small cavity and flap-like structures were also present on the CHDC-1974 254 VLPs (Fig. 11) . The CHDC-1974 A/B and C/D dimers showed a similar bend as 255 NSW-2012 dimers, although slightly less pronounced (Fig. 12) . The X-ray crystal 256 structure of CHDC-1974 P domain (5IYN) was easily fitted into the CHDC-1974 257 VLP density map (Fig. 13A) . The GI.1 S domain also fitted into the A, B, and C 258 subunits, whereas the GI.1 S domain needed to be again repositioned to occupy the D 259 subunit (Fig. 13B ). Similar to NSW-2012 VLPs, an additional density was observed 260 between the S and P domains on the D subunit (Fig. 14) . Lastly, we found that 261
Overall, these results showed that GII.4 VP1 sequences isolated over three decades 264 apart remained structurally conserved. This could imply that other GII.4 VP1 265 sequences also form T=4 VLPs when expressed in insect cells, especially since these 266 two sequences had only 89% amino acid identity. More importantly, the GII.4 267 noroviruses have dominated epidemics over the past decade and this structural feature 268 could represent a selective advantage over other GII genotypes that have a T=3 269
capsid. 270 271

Structural implications of the T=4 VLPs 272
Our new discovery of these T=4 GII.4 VLPs could have major implications for 273 vaccine development. Negative stain EM images of the GII.4c VLPs that are currently 274 tested in clinical trials showed the typical norovirus morphology (6, 31). However, the 275 size determination and the structure are not available. 276
277
In general, studies have shown that norovirus-specific antibody titers were raised after 278 vaccination with VLPs, but the levels of protection were not strongly improved 279 compared to placebo groups (32). It is tempting to speculate that the GII.4c VLPs 280 might also form T=4 particles, since the GII.4c and NSW-2012 shared 94% amino 281 acid identity; most (28 of 31) of the substitutions were located in the P domain; and 282 the hinge region was identical (Fig. 1) . Therefore, this might suggest that the host 283 could produces neutralizing antibodies against epitopes on the T=4 VLPs that were 284 not as accessible on T=3 virions and that efficacy is difficult. Indeed, we have 285 identified several Nanobodies that bind to occluded regions on the T=4 GII.4 VLPsIn order to validate if the GII.4 virions actually assemble into T=3 a cryo-EM 289 structure would be valuable, however norovirus virions are challenging to prepare in 290 large quantities. Nevertheless, when we compare EM images of GII.4 virions with 291 these T=4 VLPs we found that the virions were smaller (Fig. 15) 
Summary 296
At least two important outcomes from this new discovery of these GII.4 T=4 VLPs 297 will be acknowledged. Firstly, the GII.4 VLPs might influence results from previous 298 studies that assumed norovirus VLPs were morphologically similar to virions. For 299 example, the molecular weight of the T=3 and T=4 VLPs would be ~10.5 mDa (180 × 300 VP1) and ~14 mDa (240 × VP1), respectively. This mass difference would affect 301 results in mass spectrometry, Biacore, and isothermal titration calorimetry. Secondly, 302 the VLP vaccines that could be composed of T=4 particles might produce 303 complicating immune responses. For example, the cavity and flap-like structures on 304 the T=4 could elicit some antibodies that are not recognized by T=3 virions. 305
Ultimately, when a patient is immunized with T=4 VLPs, the immune response with 306 virions could effectively be lower.
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